Glooko Gets $16.5M Injection For Its Diabetes Management Platform

Glooko Diabetes management startup Glooko, which sells a unified diabetes data management healthcare service, which includes Bluetooth-enabled hardware to import blood glucose readings from a range of (proprietary) glucose meters to make it easier for doctors to remotely monitor patients, has pulled in a $16.5 million Series B round. Read More

You can leave a response, or trackback from your own site.

Leave a Reply